Buch
Cancer Policy: Pharmaceutical Safety
June M. McKoy; Dennis P. West (Hrsg.)
106,99
EUR
Lieferzeit 12-13 Tage
Übersicht
Verlag | : | Springer International Publishing |
Buchreihe | : | Cancer Treatment and Research (Bd. 171) |
Sprache | : | Englisch |
Erschienen | : | 16. 01. 2019 |
Einband | : | Gebunden |
Höhe | : | 235 mm |
Breite | : | 155 mm |
ISBN | : | 9783319438948 |
Sprache | : | Englisch |
Inhaltsverzeichnis
Pharmacovigilance programs: Do they improve Cancer Drug Safety?.- Impact of Cost on the Safety of Cancer pharmaceuticals.- Assessing pharmaceutical safety in Geriatric Oncology.- Cancer co-Morbidity: Implications for Drug Safety.- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions?.- Pharmacovigilance of alternative medications in the Cancer Setting.- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology.- Biosimilars: Are they really safe? .- Natural Language processing: improving the identification and communication of Cancer Drug Safety.- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety.- Anatomy of Risk Evaluation and Mitigation Strategies (REMS).- Cancer Drug Toxicity: Moving from patient to Survivor.